Letter to the editor: the effect of long-term alendronate treatment on cortical thickness of the proximal femur.
作者信息
Koh Joyce S B, Ng Alvin C M, Png Meng Ai, Howe Tet Sen
出版信息
Clin Orthop Relat Res. 2011 Dec;469(12):3509-10; author reply 3511-12. doi: 10.1007/s11999-011-2129-y.
Abstract
摘要
相似文献
1
Letter to the editor: the effect of long-term alendronate treatment on cortical thickness of the proximal femur.致编辑的信：长期阿仑膦酸盐治疗对股骨近端皮质厚度的影响
Clin Orthop Relat Res. 2011 Dec;469(12):3509-10; author reply 3511-12. doi: 10.1007/s11999-011-2129-y.
2
The effect of long-term alendronate treatment on cortical thickness of the proximal femur.长期阿伦膦酸钠治疗对股骨近端皮质厚度的影响。
Clin Orthop Relat Res. 2012 Jan;470(1):291-8. doi: 10.1007/s11999-011-1985-9. Epub 2011 Jul 20.
3
Effects of denosumab on the geometry of the proximal femur in postmenopausal women in comparison with alendronate.与阿仑膦酸钠相比，地诺单抗对绝经后女性股骨近端几何形态的影响。
J Clin Densitom. 2008 Jul-Sep;11(3):351-9. doi: 10.1016/j.jocd.2008.04.001. Epub 2008 May 20.
4
Use of alendronate after 5 years of treatment.
JAMA. 2007 May 9;297(18):1979; author reply 1980-1. doi: 10.1001/jama.297.18.1979-a.
5
Use of alendronate after 5 years of treatment.
JAMA. 2007 May 9;297(18):1979; author reply 1980-1. doi: 10.1001/jama.297.18.1979-b.
6
Use of alendronate after 5 years of treatment.
JAMA. 2007 May 9;297(18):1979-80; author reply 1980-1. doi: 10.1001/jama.297.18.1979-c.
7
Additive impact of alfacalcidol on bone mineral density and bone strength in alendronate treated postmenopausal women with reduced bone mass.阿法骨化醇对接受阿仑膦酸钠治疗的绝经后骨量减少女性的骨矿物质密度和骨强度的叠加影响。
J Musculoskelet Neuronal Interact. 2011 Mar;11(1):34-45.
8
[FACT study].[事实研究]
Nihon Rinsho. 2007 Nov 28;65 Suppl 9:280-5.
9
Cyclical alendronate treatment in postmenopausal women with osteoporosis.绝经后骨质疏松症女性的周期性阿仑膦酸盐治疗。
Int J Gynaecol Obstet. 2005 Nov;91(2):182-4. doi: 10.1016/j.ijgo.2005.06.026. Epub 2005 Aug 11.
10
[An advantage for compliance: alendronate once weekly].[依从性方面的一个优势：阿仑膦酸钠每周一次]
MMW Fortschr Med. 2005 Dec 8;147(49-50):75.
引用本文的文献
1
Atypical subtrochanteric femoral shaft fractures: role for mechanics and bone quality.非典型股骨转子下骨折：力学与骨质的作用
Arthritis Res Ther. 2012 Aug 29;14(4):220. doi: 10.1186/ar4013.
本文引用的文献
1
The effect of long-term alendronate treatment on cortical thickness of the proximal femur.长期阿伦膦酸钠治疗对股骨近端皮质厚度的影响。
Clin Orthop Relat Res. 2012 Jan;470(1):291-8. doi: 10.1007/s11999-011-1985-9. Epub 2011 Jul 20.
2
Distribution of atypical fractures and cortical stress lesions in the femur: implications on pathophysiology.股骨非典型骨折和皮质骨应力性损伤的分布：对发病机制的影响。
Singapore Med J. 2011 Feb;52(2):77-80.
3
Atypical subtrochanteric and diaphyseal femoral fractures: report of a task force of the American Society for Bone and Mineral Research.非典型转子下和骨干股骨骨折：美国骨矿研究学会工作组报告。
J Bone Miner Res. 2010 Nov;25(11):2267-94. doi: 10.1002/jbmr.253.
4
A longitudinal HR-pQCT study of alendronate treatment in postmenopausal women with low bone density: Relations among density, cortical and trabecular microarchitecture, biomechanics, and bone turnover.一项关于阿仑膦酸钠治疗绝经后低骨密度女性的纵向 HR-pQCT 研究：骨密度、皮质和小梁微结构、生物力学和骨转换之间的关系。
J Bone Miner Res. 2010 Dec;25(12):2558-71. doi: 10.1002/jbmr.157. Epub 2010 Jun 18.
5
Femoral cortical stress lesions in long-term bisphosphonate therapy: a herald of impending fracture?长期双膦酸盐治疗中的股骨皮质骨应力性病变：预示即将发生骨折？
J Orthop Trauma. 2010 Feb;24(2):75-81. doi: 10.1097/BOT.0b013e3181b6499b.
6
Association of low-energy femoral fractures with prolonged bisphosphonate use: a case control study.低能量股骨骨折与长期使用双膦酸盐的关联：一项病例对照研究。
Osteoporos Int. 2009 Aug;20(8):1353-62. doi: 10.1007/s00198-008-0805-x. Epub 2008 Dec 9.
7
An emerging pattern of subtrochanteric stress fractures: a long-term complication of alendronate therapy?粗隆下应力性骨折的一种新出现模式：阿仑膦酸盐治疗的一种长期并发症？
Injury. 2008 Feb;39(2):224-31. doi: 10.1016/j.injury.2007.08.036. Epub 2008 Jan 28.
8
Subtrochanteric insufficiency fractures in patients on alendronate therapy: a caution.接受阿仑膦酸盐治疗的患者发生转子下不全骨折：一则警示
J Bone Joint Surg Br. 2007 Mar;89(3):349-53. doi: 10.1302/0301-620X.89B3.18146.
Zotero 插件